| Impact of iron deficiency on exercise capacity and outcome in heart failure with reduced, mid-range and preserved ejection fraction |
15 |
| Effects of sacubitril/valsartan on functional status and exercise capacity in real-world patients |
8 |
| Spironolactone to increase natriuresis in congestive heart failure with cardiorenal syndrome |
6 |
| Economic and social impact of increased cardiac rehabilitation uptake and cardiac telerehabilitation in Belgium - a cost-benefit analysis |
6 |
| Age at death of major cardiovascular diseases in 13 cohorts. The seven countries study of caraiovascular diseases 45-year follow-up |
6 |
| Treatment patterns in anticoagulant therapy in patients with newly diagnosed atrial fibrillation in Belgium: results from the GARFIELD-AF registry |
5 |
| Loop diuretic down-titration in stable chronic heart failure is often achievable, especially when urinary chloride concentration is low |
5 |
| Impact of sacubitril/valsartan on heart failure admissions: insights from real-world patient prescriptions |
5 |
| Meta-analysis of randomized trials on percutaneous patent foramen ovale closure for prevention of migraine |
4 |
| New-onset atrial fibrillation is associated with increased mortality in critically ill patients: a systematic review and meta-analysis |
4 |
| In-hospital and long-term prognoses of patients with a mid-range ejection fraction after an ST-segment myocardial infarction |
4 |
| Association of MIR-499a expression and seed region variant (rs3746444) with cardiovascular disease in Egyptian patients |
4 |
| Percutaneous repair of mitral valve regurgitation in patients with severe heart failure: comparison with optimal medical treatment |
4 |
| Serum albumin level and long-term outcome in acute heart failure |
4 |
| QT prolongation and sudden cardiac death risk in hypertrophic cardiomyopathy |
3 |
| Left atrial remodelling may predict exercise capacity in obstructive sleep apnoea patients |
3 |
| Association of QRS duration with left ventricular volume and ejection fraction after anterior myocardial infarction assessed by gated single photon emission computed tomography |
3 |
| Drug-induced arterial hypertension - a frequently ignored cause of secondary hypertension: a review |
3 |
| PM2.5 exposure aggravates left heart failure induced pulmonary hypertension |
3 |
| Reference values for maximum work rate in apparently healthy Dutch/Flemish adults: data from the LowLands fitness registry |
3 |
| Elevated oxidative DNA damage in patients with coronary artery disease and its association with oxidative stress biomarkers |
3 |
| Long-term outcome of conservative and invasive treatment in patients with hypertrophic obstructive cardiomyopathy |
2 |
| Comparison of central hemodynamic parameters for young basketball athletes and control group |
2 |
| Defining quality indicators for heart failure in general practice |
2 |
| Lower plasma protein C activity is associated with early myocardial necrosis and no-reflow phenomenon in patients with ST elevation myocardial infarction |
2 |
| A simple discharge risk model for predicting 1-year mortality in hospitalised acute decompansated heart failure patients with reduced ejection fraction |
2 |
| The strength of the multivariable associations of major risk factors predicting coronary heart disease mortality is homogeneous across different areas of the Seven Countries Study during 50-year follow-up |
2 |
| Impact of statin use on high sensitive troponin T levels with moderate exercise |
2 |
| Optimising standards of care of heart failure in general practice the OSCAR-HF pilot study protocol |
2 |
| Moderate, but not vigorous, intensity exercise training reduces C-reactive protein |
2 |
| Statin related adverse effects and patient education: a study from resource limited settings |
2 |
| Prognostic value of sST2 and NT-proBNP at admission in heart failure with preserved, mid-ranged and reduced ejection fraction |
2 |
| Clinical outcomes of heart-team-guided treatment decisions in high-risk patients with aortic valve stenosis in a health-economic context with limited resources for transcatheter valve therapies |
2 |
| Dual antiplatelet therapy after percutaneous left atrial appendage occlusion: single center experience with the Amplatzer Cardiac plug |
2 |
| Assessing the landscape of percutaneous coronary chronic total occlusion treatment in Belgium and Luxembourg: the Belgian Working Group on Chronic Total Occlusions (BWGCTO) registry |
2 |
| Monocentric experience of leadless pacing with focus on challenging cases for conventional pacemaker |
2 |
| Fragmented QRS complexes are associated with left ventricular dysfunction in patients with type-2 diabetes mellitus: a two-dimensional speckle tracking echocardiography study |
1 |
| Major adverse cardiovascular events while awaiting staged non-culprit percutaneous coronary intervention after ST-segment elevation myocardial infarction |
1 |
| Arterial stiffness in adult patients after coarctation of aorta repair and with bicuspid aortic valve |
1 |
| Diabetes mellitus is not associated with worse vascular outcome following percutaneous transfemoral transcatheter aortic valve implantation |
1 |
| Chronic kidney disease predicts atrial fibrillation in patients with ST-segment elevation myocardial infarction treated by primary percutaneous coronary intervention |
1 |
| Rosuvastatin inhibits high glucose-stimulated upregulation of VCAM-1 via the MAPK-signalling pathway in endothelial cells |
1 |
| Cardiac sarcoidosis: a diagnostic and therapeutic challenge |
1 |
| Variability of longitudinal strain measurements: levelling the playing field |
1 |
| Transcatheter aortic valve implantation compared with surgical aortic valve replacement in patients with anaemia |
1 |
| Serum paraoxonase activity in patients with ischaemic and nonischaemic dilated cardiomyopathy |
1 |
| Investigation of mindin levels in hypertensive patients with left ventricular hypertrophy and QRS fragmentation on electrocardiography |
1 |
| Prevention of minor myocardial injury after elective percutaneous coronary intervention: comparison of ticagrelor versus clopidogrel |
1 |
| Using mHealth interventions to promote cardiovascular health |
1 |
| Angioedema: a rare and sometimes delayed side effect of angiotensin-converting enzyme inhibitors |
1 |
